Novo CEO pressed by Senate to cut costs of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen informed lawmakers the company would take into consideration new talks with insurers regarding the listing price ranges of Wegovy and copyright should they pledge to keep the medicines on their own formularies. https://arizona-hard-tea-carbs11887.like-blogs.com/30508648/the-ultimate-guide-to-healthcare-news